Carlos A. Lopez, MD, MPH, and Emily S. Tonorezos, MD, MPH
In this case report, we present a non-Hodgkin lymphoma survivor who was incidentally found to have non–small-cell lung cancer 30 years after undergoing treatment that included mantle radiation. We discuss the treatment-related risk factors for lung cancer in this population and potential implications for long-term follow-up.
Abhinav Gupta, Thomas J. Pugh, MD, Elaine Lam, MD, et al
This case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?
FoundationOne®CDx analyzes all recommended genomic biomarkers for solid tumors, including companion diagnostic indications with direct paths to therapy. This one test can help guide therapy selection and clinical trial options for more patients. Read More
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
Carlos A. Lopez, MD, MPH, and Emily S. Tonorezos, MD, MPH
Abhinav Gupta, Thomas J. Pugh, MD, Elaine Lam, MD, et al 
